Results 251 to 260 of about 478,784 (306)

Integrating clinical outcomes with molecular simulations to guide the selection of non-classical EGFR-TKIs: A comprehensive analysis and development of treatment strategies. [PDF]

Exp Ther Med
Wei F, Niu N, Li C, Gao G, Li N, Wang Y.
europepmc   +1 more source

Establishment and functional characterization of an EGFR-amplified tumoroid from squamous cell carcinoma of unknown primary. [PDF]

Hum Cell
Iwai M, Yokota E, Yukawa T, Matsumoto K, Urano T, Nakashima K, Doihara H, Takigawa N, Fujiwara H, Akiyama T, Haisa M, Naomoto Y, Fukazawa T, Yamatsuji T.   +13 more
europepmc   +1 more source

Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma. [PDF]

In Vivo
Chang CC, Hung MY, Weng YS, Chang CM, Hsu FT, Chen YH, Chen JH.   +6 more
europepmc   +1 more source

Genetic overlap between estimated glomerular filtration rate and cardiovascular disease identifies potential targets for cardiorenal syndrome. [PDF]

Ren Fail
Li W, Chen Y, Xiong W, Yuan S.
europepmc   +1 more source

Sequential EGFR inhibition sensitizes glioblastoma to temozolomide. [PDF]

Trends Pharmacol Sci
Yu X, Wu R, Cheng SY.
europepmc   +1 more source